Drug Type Small molecule drug |
Synonyms Amosulalol, Amosulalol hydrochloride (JP17), LY 137224 + [5] |
Target |
Action antagonists |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (29 Mar 1988), |
Regulation- |
Molecular FormulaC18H25ClN2O5S |
InChIKeyJRVCPDVOFCWKAG-UHFFFAOYSA-N |
CAS Registry70958-86-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01469 | Amosulalol Hydrochloride | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypertension | Japan | 29 Mar 1988 |





